NAD replenishment with nicotinamide mononucleotide protects blood–brain barrier integrity and attenuates delayed tissue plasminogen activator‐induced haemorrhagic transformation after cerebral ischaemia

No abstract is available for this paper.

• Publication year

  2017

• Venue

  British Journal of Pharmacology

• Publication date

  2017-08-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/bph.13979PMID 28812311PMCID PMC5647191
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Toll-Like Receptor 4 Mediates Hemorrhagic Transformation After Delayed Tissue Plasminogen Activator Administration in In Situ Thromboembolic Stroke

  2017cited by this paper
• The novel exercise-induced hormone irisin protects against neuronal injury via activation of the Akt and ERK1/2 signaling pathways and contributes to the neuroprotection of physical exercise in cerebral ischemia.

  2017cited by this paper
• NAD replenishment with nicotinamide mononucleotide protects blood–brain barrier integrity and attenuates delayed tissue plasminogen activator‐induced haemorrhagic transformation after cerebral ischaemia

  2017cited by this paper
• Nicotinamide mononucleotide attenuates brain injury after intracerebral hemorrhage by activating Nrf2/HO-1 signaling pathway

  2017cited by this paper
• Depletion of NAD pool contributes to impairment of endothelial progenitor cell mobilization in diabetes.

  2016cited by this paper
• Head to Head Comparison of Short-Term Treatment with the NAD+ Precursor Nicotinamide Mononucleotide (NMN) and 6 Weeks of Exercise in Obese Female Mice

  2016cited by this paper
• Response to Letter Regarding Article, "Matrix Metalloprotease 3 Exacerbates Hemorrhagic Transformation and Worsens Functional Outcomes in Hyperglycemic Stroke".

  2016cited by this paper
• Nicotinamide mononucleotide supplementation reverses vascular dysfunction and oxidative stress with aging in mice

  2016cited by this paper
• Hydrogen Sulfide Attenuates Tissue Plasminogen Activator-Induced Cerebral Hemorrhage Following Experimental Stroke

  2016cited by this paper
• Neuroprotective Efficacy of an Aminopropyl Carbazole Derivative P7C3‐A20 in Ischemic Stroke

  2016cited by this paper
• The potential regulatory roles of NAD(+) and its metabolism in autophagy.

  2016cited by this paper
• Matrix metalloproteinases in the brain and blood–brain barrier: Versatile breakers and makers

  2016cited by this paper
• AMPK↔Sirt1: From a signaling network to a combination drug.

  2016cited by this paper
• Nicotinamide mononucleotide inhibits post-ischemic NAD(+) degradation and dramatically ameliorates brain damage following global cerebral ischemia.

  2016influential reference
• Hepatic NAD+ deficiency as a therapeutic target for non‐alcoholic fatty liver disease in ageing

  2016cited by this paper
• Matrix Metalloprotease 3 Exacerbates Hemorrhagic Transformation and Worsens Functional Outcomes in Hyperglycemic Stroke

  2016cited by this paper
• Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP

  2015cited by this paper
• NAMPT as a Therapeutic Target against Stroke.

  2015cited by this paper
• The Concise Guide to PHARMACOLOGY 2015/16: Overview

  2015cited by this paper
• Regenerative Neurogenesis After Ischemic Stroke Promoted by Nicotinamide Phosphoribosyltransferase–Nicotinamide Adenine Dinucleotide Cascade

  2015cited by this paper
• The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands

  2015cited by this paper
• Focal embolic cerebral ischemia in the rat

  2015cited by this paper
• Understanding the Functions of Endogenous and Exogenous Tissue-Type Plasminogen Activator During Stroke

  2015cited by this paper
• Effect of nicotinamide mononucleotide on brain mitochondrial respiratory deficits in an Alzheimer’s disease-relevant murine model

  2015cited by this paper
• Physiological and pathophysiological roles of NAMPT and NAD metabolism

  2015influential reference
• The Concise Guide to PHARMACOLOGY 2015/16: Enzymes

  2015cited by this paper
• Recombinant tissue plasminogen activator promotes, and progesterone attenuates, microglia/macrophage M1 polarization and recruitment of microglia after MCAO stroke in rats.

  2015cited by this paper
• Melatonin alleviates brain injury in mice subjected to cecal ligation and puncture via attenuating inflammation, apoptosis, and oxidative stress: the role of SIRT1 signaling

  2015influential reference
• Minocycline ameliorates hypoxia-induced blood-brain barrier damage by inhibition of HIF-1α through SIRT-3/PHD-2 degradation pathway.

  2015cited by this paper
• Experimental design and analysis and their reporting: new guidance for publication in BJP

  2015cited by this paper
• Nicotinamide Phosphoribosyltransferase Facilitates Post‐Stroke Angiogenesis

  2015cited by this paper
• Poly(ADP-ribose) Polymerase-1 Inhibition in Brain Endothelium Protects the Blood—Brain Barrier under Physiologic and Neuroinflammatory Conditions

  2015cited by this paper
• Normobaric Hyperoxia Slows Blood–Brain Barrier Damage and Expands the Therapeutic Time Window for Tissue-Type Plasminogen Activator Treatment in Cerebral Ischemia

  2015cited by this paper
• SIRT1 inhibition by sirtinol aggravates brain edema after experimental subarachnoid hemorrhage

  2014cited by this paper
• NAD+ and sirtuins in aging and disease.

  2014cited by this paper
• Intracellular NAMPT-NAD+-SIRT1 cascade improves post-ischaemic vascular repair by modulating Notch signalling in endothelial progenitors.

  2014cited by this paper
• Extracellular Visfatin has Nicotinamide Phosphoribosyltransferase Enzymatic Activity and is Neuroprotective Against Ischemic Injury

  2014cited by this paper
• ARRB1/β-arrestin-1 mediates neuroprotection through coordination of BECN1-dependent autophagy in cerebral ischemia

  2014cited by this paper
• Vascular smooth muscle cell apoptosis is an early trigger for hypothyroid atherosclerosis.

  2014cited by this paper
• Specific ablation of Nampt in adult neural stem cells recapitulates their functional defects during aging

  2014cited by this paper
• IMM‐H004 prevents toxicity induced by delayed treatment of tPA in a rat model of focal cerebral ischemia involving PKA‐and PI3K‐dependent Akt activation

  2014cited by this paper
• Recombinant ADAMTS13 reduces tissue plasminogen activator‐induced hemorrhage after stroke in mice

  2013cited by this paper
• Induction of autophagy contributes to the neuroprotection of nicotinamide phosphoribosyltransferase in cerebral ischemia

  2012cited by this paper
• Age-Associated Changes In Oxidative Stress and NAD+ Metabolism In Human Tissue

  2012cited by this paper
• Blood-brain barrier breakdown in acute and chronic cerebrovascular disease.

  2011influential reference
• A fluorometric assay for high-throughput screening targeting nicotinamide phosphoribosyltransferase.

  2011cited by this paper
• Nicotinamide phosphoribosyltransferase protects against ischemic stroke through SIRT1‐dependent adenosine monophosphate–activated kinase pathway

  2011cited by this paper
• Inhibition of VEGF signaling pathway attenuates hemorrhage after tPA treatment

  2011cited by this paper
• Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice.

  2011cited by this paper
• Animal Research: Reporting In Vivo Experiments: The ARRIVE Guidelines

  2010cited by this paper
• Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide.

  2009cited by this paper
• Atorvastatin Extends the Therapeutic Window for tPA to 6 h after the Onset of Embolic Stroke in Rats

  2009influential reference
• Early Disruption of the Blood–Brain Barrier After Thrombolytic Therapy Predicts Hemorrhage in Patients With Acute Stroke

  2008cited by this paper
• Extension of the Thrombolytic Time Window With Minocycline in Experimental Stroke

  2008influential reference
• Matrix Metalloproteinase-Mediated Disruption of Tight Junction Proteins in Cerebral Vessels is Reversed by Synthetic Matrix Metalloproteinase Inhibitor in Focal Ischemia in Rat

  2007cited by this paper
• The molecular machinery of Keilin's respiratory chain.

  2003cited by this paper
• Hemoglobin-Induced Cytotoxicity in Rat Cerebral Cortical Neurons: Caspase Activation and Oxidative Stress

  2002cited by this paper
• The effects of nicotinamide on energy metabolism following transient focal cerebral ischemia in Wistar rats.

  2002cited by this paper
• Risk Factors for Severe Hemorrhagic Transformation in Ischemic Stroke Patients Treated With Recombinant Tissue Plasminogen Activator: A Secondary Analysis of the European-Australasian Acute Stroke Study (ECASS II)

  2001cited by this paper
• Emerging roles of caspase-3 in apoptosis

  1999cited by this paper
• Cerebral ischemia : molecular and cellular pathophysiology

  1999cited by this paper
• Tissue type plasminogen activator amplifies hemoglobin-induced neurotoxicity in rat neuronal cultures.

  1999cited by this paper
• A R T I C L E I N F O

  year unknowncited by this paper

• Predicting cerebral acetylcholine dynamics with huperzine A pharmacokinetics in blood via mPBPK-PD modeling.

  2026cites this paper
• NADPH Exerts Neuroprotection in Ischemic Stroke by Reinforcing Blood-Brain Barrier Integrity and Stimulating Angiogenesis.

  2026cites this paper
• Network of nicotinamide mononucleotide biosynthesis: substrate tracking, rate-limiting enzyme, and regulatory strategy

  2025cites this paper
• NMN Supplementation Inhibits Endothelial Cell ROS-Mediated Src/Pi3k/Akt Signaling Pathway to Protect High-Altitude Blood-Retinal Barrier

  2025cites this paper
• Estrogens protect bone mass by inhibiting NAD+ metabolism in osteoclasts

  2025cites this paper
• Proteoglycan 4 attenuates ischemic post-stroke hemorrhagic transformation and blood-brain barrier disruption

  2025influential citation
• Mortality, functional outcome, and bleeding risk after early versus delayed thrombectomy.

  2025cites this paper
• A Single-Atom FeCo-N6 Nanozyme with Dual Enzyme-Mimicking Activity Reverses Redox Imbalance and Bioenergetic Collapse in Ischemic Stroke.

  2025cites this paper
• Nicotinamide Mononucleotide Alleviates the Development of Fibrotic Cataract by Modulating the Nrf2/FPN1 Signaling Pathway

  2025cites this paper
• Molecular Mediators of Neutrophil Primary Granule Release Following Acute Ischemic Stroke and their Associated Epigenetic Modulation by HDAC2

  2025cites this paper
• γ-Glutamylcysteine ameliorates blood-brain barrier permeability and neutrophil extracellular traps formation after ischemic stroke by modulating Wnt/β-catenin signalling in mice.

  2024cites this paper
• Metrnl as a secreted protein: Discovery and cardiovascular research.

  2024cites this paper
• Photocatalytic Sulfonylation: Innovations and Applications.

  2024cites this paper
• Nicotinamide Mononucleotide Supplementation: Understanding Metabolic Variability and Clinical Implications

  2024cites this paper
• Prophylactic nicotinamide mononucleotide (NMN) mitigates CSDS-induced depressive-like behaviors in mice via preserving of ATP level in the mPFC.

  2024cites this paper
• Molecularly imprinted polymer-coated silica microbeads for high-performance liquid chromatography.

  2024cites this paper
• Nicotinamide adenine dinucleotide treatment confers resistance to neonatal ischemia and hypoxia: effects on neurobehavioral phenotypes

  2024cites this paper
• Synthesis and evaluation of ginsenosides imprinted polymer-based chromatographic stationary phase.

  2023cites this paper
• Activated neutrophil-derived exosomes contribute to blood-brain barrier damage and hemorrhagic transformation after cerebral ischemia/reperfusion.

  2023cites this paper
• Adipose tissue as a therapeutic target for vascular damage in Alzheimer's disease

  2023cites this paper
• The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update

  2023cites this paper
• Propofol Suppresses LPS-induced BBB Damage by Regulating miR-130a-5p/ZO-1 Axis

  2023cites this paper
• The Role of Matrix Metalloproteinases in Hemorrhagic Transformation in the Treatment of Stroke with Tissue Plasminogen Activator

  2023cites this paper
• Brain-Targeting Emodin Mitigates Ischemic Stroke via Inhibiting AQP4-Mediated Swelling and Neuroinflammation

  2023cites this paper
• The identification of new roles for nicotinamide mononucleotide after spinal cord injury in mice: an RNA-seq and global gene expression study

  2023cites this paper
• Forced treadmill running modifies gut microbiota with alleviations of cognitive impairment and Alzheimer's disease pathology in 3xTg-AD mice.

  2023cites this paper
• Importance of NAD+ Anabolism in Metabolic, Cardiovascular and Neurodegenerative Disorders

  2022cites this paper
• Role of NAD+ and FAD in Ischemic Stroke Pathophysiology: An Epigenetic Nexus and Expanding Therapeutic Repertoire

  2022cites this paper
• Nicotinamide mononucleotide increases cell viability and restores tight junctions in high-glucose-treated human corneal epithelial cells via the SIRT1/Nrf2/HO-1 pathway.

  2022cites this paper
• Nicotinamide Mononucleotide Prevents Cisplatin-Induced Mitochondrial Defects in Cortical Neurons Derived from Human Induced Pluripotent Stem Cells

  2022cites this paper
• Distribution of Nicotinamide Mononucleotide After Intravenous Injection in Normal and Ischemic Stroke Mice.

  2022cites this paper
• Potential therapeutic effects of Nrf2 activators on intracranial hemorrhage

  2021cites this paper
• Pharmacology and Potential Implications of Nicotinamide Adenine Dinucleotide Precursors

  2021cites this paper
• Nicotinamide mononucleotide attenuates doxorubicin-induced cardiotoxicity by reducing oxidative stress, inflammation and apoptosis in rats.

  2021cites this paper
• Nicotinamide Mononucleotide Adenylyltransferase 1 Regulates Cerebral Ischemia–Induced Blood–Brain Barrier Disruption Through NAD+/SIRT1 Signaling Pathway

  2021cites this paper
• MMP-2/9-cleaved occludin promotes endothelia cell death in ischemic stroke

  2021cites this paper
• Protective Effects of Nicotinamide Adenine Dinucleotide and Related Precursors in Alzheimer’s Disease: A Systematic Review of Preclinical Studies

  2021cites this paper
• NAD+ and Cardiovascular Diseases.

  2021cites this paper
• Loss of Wip1 aggravates brain injury after ischaemia/reperfusion by overactivating microglia

  2021cites this paper
• NAD+ metabolism and its roles in cellular processes during ageing

  2020cites this paper
• NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis.

  2020cites this paper
• Nicotinamide riboside rescues angiotensin II–induced cerebral small vessel disease in mice

  2020cites this paper
• Dl-NBP (Dl-3-N-Butylphthalide) Treatment Promotes Neurological Functional Recovery Accompanied by the Upregulation of White Matter Integrity and HIF-1α/VEGF/Notch/Dll4 Expression

  2020cites this paper
• Plasma Adipokines in Patients Resuscitated from Cardiac Arrest: Difference of Visfatin between Survivors and Nonsurvivors

  2020cites this paper
• Nicotinamide mononucleotide (NMN) supplementation promotes neurovascular rejuvenation in aged mice: transcriptional footprint of SIRT1 activation, mitochondrial protection, anti-inflammatory, and anti-apoptotic effects

  2020cites this paper
• Cerebral organoids transplantation improves neurological motor function in rat brain injury

  2020cites this paper
• Copper-catalyzed C-H [3 + 2] annulation of N-substituted anilines with α-carbonyl alkyl bromides via C(sp3)-Br/C(sp2)-H functionalization.

  2020cites this paper
• Cannabidiol alleviates hemorrhagic shock‐induced neural apoptosis in rats by inducing autophagy through activation of the PI3K/AKT pathway

  2020cites this paper
• High plasma levels of pro-inflammatory factors interleukin-17 and interleukin-23 are associated with poor outcome of cardiac-arrest patients: a single center experience

  2020cites this paper
• Metal‐Free Oxidative Decarboxylative Heteroannulation of Alkynyl Carboxylic Acids with Sulfinates and tert‐Butyl Nitrite toward 2,2‐Disulfonyl‐2H‐Azirines

  2020cites this paper
• Nicotinamide Mononucleotide: A Promising Molecule for Therapy of Diverse Diseases by Targeting NAD+ Metabolism

  2020cites this paper
• miR-330 regulates Drp-1 mediated mitophagy by targeting PGAM5 in a rat model of permanent focal cerebral ischemia.

  2020cites this paper
• The Science Behind NMN-A Stable, Reliable NAD+Activator and Anti-Aging Molecule.

  2020cites this paper
• Manganese(iii)-promoted tandem phosphinoylation/cyclization of 2-arylindoles/2-arylbenzimidazoles with disubstituted phosphine oxides.

  2020cites this paper
• YiQiFuMai Lyophilized Injection ameliorates tPA-Induced hemorrhagic transformation by inhibiting cytoskeletal rearrangement associated with ROCK1 and NF-κB signaling pathways.

  2020cites this paper
• FUNDC1-dependent mitophagy induced by tPA protects neurons against cerebral ischemia-reperfusion injury

  2020cites this paper
• Impact of nicotinamide mononucleotide on transplanted mouse ovarian tissue.

  2020cites this paper
• NMN does not protect the ovarian reserve from cancer treatments

  2020cites this paper
• New progress in the approaches for blood-brain barrier protection in acute ischemic stroke.

  2019cites this paper
• Cerebral Organoids Repair Ischemic Stroke Brain Injury

  2019cites this paper
• Neuroprotective Effect of SCM-198 through Stabilizing Endothelial Cell Function

  2019cites this paper
• Rosiglitazone ameliorates tissue plasminogen activator‐induced brain hemorrhage after stroke

  2019cites this paper
• Nicotinamide mononucleotide does not protect the ovarian reserve from cancer treatments.

  2019cites this paper
• NG2-glia cell proliferation and differentiation by glial growth factor 2 (GGF2), a strategy to promote functional recovery after ischemic stroke.

  2019cites this paper
• The photoredox alkylarylation of styrenes with alkyl N-hydroxyphthalimide esters and arenes involving C-H functionalization.

  2019cites this paper
• Tissue plasminogen activator disrupts the blood-brain barrier through increasing the inflammatory response mediated by pericytes after cerebral ischemia

  2019cites this paper
• Multi-targeted Effect of Nicotinamide Mononucleotide on Brain Bioenergetic Metabolism

  2019cites this paper
• The role of endogenous tissue-type plasminogen activator in neuronal survival after ischemic stroke: friend or foe?

  2019cites this paper
• Nicotinamide Mononucleotide and Melatonin Alleviate Aging-induced Cognitive Impairment via Modulation of Mitochondrial Function and Apoptosis in the Prefrontal Cortex and Hippocampus.

  2019cites this paper
• Silver-mediated oxidative 1,2-alkylesterification of styrenes with nitriles and acids via C(sp3)-H functionalization.

  2019cites this paper
• Nicotinamide and Demographic and Disease transitions: Moderation is Best

  2019cites this paper
• Osthole alleviates inflammation by down-regulating NF-κB signaling pathway in traumatic brain injury

  2019cites this paper
• Role of acute‐phase protein ORM in a mice model of ischemic stroke

  2019cites this paper
• Targeting NAMPT as a therapeutic strategy against stroke

  2019cites this paper
• Nicotinamide adenine dinucleotide emerges as a therapeutic target in aging and ischemic conditions

  2019cites this paper
• Nicotinamide phosphoribosyltransferase aggravates inflammation and promotes atherosclerosis in ApoE knockout mice

  2019cites this paper
• Targeting NAD+ Metabolism as Interventions for Mitochondrial Disease

  2019cites this paper
• Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence.

  2018cites this paper
• Nicotinic ACh receptor α7 inhibits PDGF‐induced migration of vascular smooth muscle cells by activating mitochondrial deacetylase sirtuin 3

  2018cites this paper
• NAD replenishment with nicotinamide mononucleotide protects blood–brain barrier integrity and attenuates delayed tissue plasminogen activator‐induced haemorrhagic transformation after cerebral ischaemia

  2017cites this paper
• NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR.

  2017cites this paper